Bad news for Italy’s EMA relocation challenge
EU’s top court denies bid that Amsterdam decision was a “misuse of powers” | Complaint said The Netherlands facility wasn’t ready | Milan lost out after random pick from a fish bowl.
Generic drug maker fails to avoid inhaler patent lawsuit
A Virginia court was unconvinced that the Hatch-Waxman Act did not apply.
Teva takes long-running ‘skinny label’ suit to SCOTUS
Generics giant’s petition cites the cost of medicine and first-principles of innovation.
Moderna, Pfizer face escalating COVID vaccine patent suits
New lawsuit comes months after the pair were accused of infringing lipid nanoparticle technology.
Microsoft’s AI software unit shakes off patent suit
A Delaware court found in favour of the AI company, which Microsoft bought for $16 billion last year.
Swiss big pharma settles patent dispute with Insulet
The dispute over a patent covering a blood glucose level monitor ends with a multimillion-dollar payment and a licence agreement.
Federal Circuit rejects ADHD generic drug challenge
A major generic pharma company has failed to undo patents related to the oral suspension Quillivant XR.
USPTO and FDA unite to tackle drug pricing
The US Patent and Trademark Office and Food and Drug Administration have partnered to facilitate access to affordable drugs.
CureVac sues BioNTech over mRNA technology
Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.
Pressure-reducing eye drop patents in dispute
Licensing partners aim to prevent the introduction of a proposed eye drop generic treatment before the expiration of four patents.
